Stock ELOX ELOXX PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Eloxx Pharmaceuticals, Inc.

Equities

ELOX

US29014R2022

Delayed OTC Markets
Other stock markets
 01:33:10 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.81 USD -1.82% Intraday chart for Eloxx Pharmaceuticals, Inc. -15.84% -32.50%
Apr. 11 North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge DJ
Mar. 13 Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $30 From $60, Maintains Outperform Rating
MT
Oppenheimer Raises Eloxx Pharmaceuticals Price Target to $60 From $55, Maintains Outperform Rating
MT
Oppenheimer Adjusts Eloxx Pharmaceuticals' Price Target to $55 From $50, Keeps Outperform Rating
MT
Oppenheimer Adjusts Eloxx Pharmaceuticals Price Target to $50 From $3, Maintains Outperform Rating
MT
Piper Sandler Adjusts Eloxx Pharmaceuticals' Price Target to $1.50 from $4, Keeps Overweight Rating
MT
HC Wainwright Trims Eloxx Pharmaceuticals Price Target to $0.5 From $1, Maintains Neutral Rating
MT
B. Riley Lowers Eloxx Pharmaceuticals' Price Target to $3 from $5 After Revising Cost Capital Assumptions, Keeps Buy Rating
MT
Oppenheimer Initiates Coverage on Eloxx Pharmaceuticals With Outperform Rating, $4 Price Target
MT
HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $1 From $2, Keeps Neutral Rating
MT
HC Wainwright Adjusts Eloxx Pharmaceuticals' Price Target to $2 From $3, Maintains Neutral Rating
MT
ELOXX PHARMACEUTICALS : Mizuho Securities Starts Eloxx Pharmaceuticals at Buy With $3.10 Price Target
MT
ELOXX PHARMACEUTICALS : B. Riley Starts Eloxx Pharmaceuticals at Buy with $5 PT, Notes Compelling Turnaround Story
MT
ELOXX PHARMACEUTICALS : Piper Sandler Adjusts Price Target on Eloxx Pharmaceuticals to $4 From $6, Keeps Overweight Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ELOX Stock
  4. News Eloxx Pharmaceuticals, Inc.
  5. Analyst Reco.